Scientific Posters

FEBS 2022

Skeletal troponin I detection in the blood of patients with skeletal muscle injury

Influence of heparin on the immunodetection of cardiac troponin

AACC 2020

Diverse short-term natriuretic response in acute decompensated heart failure patients undergoing Entresto™ treatment

2020 ACVP, ASVCP, and ISACP Virtual Annual Meeting

• New immunoassays for the detection of the most common feline serum amyloid A (SAA) variants
  

ISA 2020

• New immunoassays for the selective measurement of serum amyloid A isoforms 1 and 2 in human blood

AACC 2019

• Novel neprilysin-derived BNP fragments in the plasma of heart failure patients suggest possible insights for a guided ARNi therapy
• Full-size human cardiac troponin T and its fragments in the plasma of patients with acute myocardial infarction 
  
• 
  IFCC EuroMedLab Conference 2019
• Cardiac troponins in the blood of patients with acute myocardial infarction: in what forms do they exist?
• Novel neprilysin-derived BNP fragment in the circulation: evidence from a rat model

ISACP 2018

• Recombinant canine C-reactive protein as a reliable calibrator for different types of cCRP assays
  

AACC 2018

• Human cardiac TnI degradation and antibody selection for the assay development
  
• NT-proBNP assays that are based on antibodies which are specific to nonglycosylated regions of NT-proBNP display a similar diagnostic accuracy in distinguishing heart failure patients compared to the Roche NT-proBNP assay
  

Hear Failure Congress 2018

• C-terminal fragment of IGFBP-4 is independently associated with mortality in patients hospitalized due to acute heart failure
  
• Non-hypertrophic and hypertrophic human cardiomyocytes secrete
  unprocessed ANP and BNP precursors (proANP/proBNP) and exhibit a
  similar efficiency in their processing
  

American Heart Association Scientific Sessions 2017

• Pro-Atrial natriuretic peptide (proANP) as a stable circulating ANP form that is not affected by neprilysin-mediated cleavage
  

4th Joint EFLM-UEMS Congress 2016

• Fragmentation of human cardiac troponin I from serum samples of AMI patients
  
• Human cardiac troponin T is cleaved by thrombin in serum samples
  
• N-glycosylated IGFBP-4 could be less susceptible to PAPP-A mediated proteolysis than the non-glycosylated form
  
• Searching for a BNP standard: glycosylated proBNP as a common calibrator enables improved comparability of BNP immunoassays results
  

AACC 2016

• Antibodies and recombinant standards for the Lp-PLA2 fluoroimmunoassay
  
• Different susceptibility of BNP and proBNP to neprilysin cleavage suggests a limited effect of neprilysin inhibition by LCZ696 on the level of immunoreactive BNP
  
• The influence of troponin-specific autoantibodies on measurement of cardiac troponin I in binary and ternary complexes
  
• N-glycosylation of NT-IGFBP-4 does not influence its immunodetection by the neo-epitope specific sandwich immunoassay
  

AACC 2015

• In vitro Studies of Human Cardiac Troponin I Degradation
  

IFCC EuroMedLab Conference 2015

• Processing of human proBNP in serum, EDTA-plasma and heparinized plasma: the matrix defines it all
  

XXV ISTH Congress 2015

• Evaluation of the ratios of high molecular weight fibrin degradation products (HMW FDP) to D-dimer in patients’ blood by the immunoassay equally recognizing D-dimer and HMW FDP
  

ACVIM Forum 2015

• Monoclonal antibodies specific to serum amyloid A from different species
  

AACC 2014

• A step towards D-dimer assays’ standardization: Antibodies with Equal Specificity to D-dimer and High Molecular Weight Fibrin Degradation Products
  

AACC 2013

• Investigation of immunochemical and biochemical properties of circulating IGFBP-4 fragments – novel biomarkers for cardiac risk assessment
  
• Monoclonal antibodies for detection of retinol-binding protein 4
  
• Development of immunoassays for quantification of NT-proBNP in canine blood
  
• N-glycosylated IGFBP-4 could be less susceptible to PAPP-A mediated proteolysis than the non-glycosylated form
  

AACC 2011

• N-terminal and C-terminal fragments of IGFBP-4 as new markers for short-term risk assessment of major adverse cardiac events (MACE) in patients presenting with ischemia
  
• Evidence for processing of human pro-B-type natriuretic peptide in the circulation
  

AACC 2010    

• The Role of Furin and Corin in Processing of Human B-type Natriuretic Peptide Precursor
  
• Sandwich immunoassay prototypes for human LMW adiponectin and for complex of adiponectin with serum albumin
  
• B-type natriuretic peptide measurements by two assays utilizing antibodies with different epitope specificity
  

AACC 2009

• New insights into human proBNP processing
  
• New antibodies for dPAPP-A immunoassays
  

AACC 2008

• Processing of proBNP is affected by threonine 71 glycosylation
  
• Immunohistochemical identification of PAPP-A in human atherosclerotic plaques
  
• Immunochemical properties of PAPP-A from human atherosclerotic coronary arteris
  
• Different proBNP&NT-proBNP glycosylation: new regul. level in proBNP processing
  
• Development of sandwich immunoassays for measuring human adiponectin
  

AACC 2007

• Rec.proBNP Expressed in Eukaryotic Cells as Stable Standard for BNP Immunoassay
  
• ProBNP is a Major Form of BNP Immunoreactivity in Blood of Patients with HF
  
• Glycosylation of NT-proBNP Molecules and NT-proBNP Immunoassays
  

AACC 2005

• New sensitive sandwich assay for quantification of BNP in human blood
  
• NT-proBNP stability & immunoassays using MAbs with different epitope specifity
  
• Autoantibodies are associated with negative interference in cTnI assays
  

Other Hytest posters

• New type of TnI assay with reduced susceptibility to the presence of autoantibodies in blood sample
  
• Rubella Polyvalent Vaccine Candidate Based on Chimeric hsp70 Containing Constructs
  
• Sandwich immunoassays to detect adiponectin without cross-reactivity with complement component C1q
  
• PAPP-A from human atherosclerotic plaques is an active enzyme that cleaves IGFBP-4
  

Other posters

• Reference Range Study Using a High Sensitivity cTnI Assay in Development for the Sgx Clarity™ System
  
• BNP Assay in Development for the Sgx Clarity™ System Demonstrates Increased Clinical Sensitivity Relative to a Conventional BNP Immunoassay